Immuno Concepts, founded in 1979, is a leading provider of state-of-the-art diagnostic assays for systemic rheumatic diseases. Pioneering the use of HEp-2 cells for ANA detection and introducing the clinically superior HEp-2000 substrate, Immuno Concepts has garnered global recognition for its innovative approach to autoantibody detection.
With a commitment to developing cutting-edge products like the FDA-cleared Immuno Concepts IgG Anti-nDNA Fluorescent Test System, Immuno Concepts continues to set industry standards in the field of immunofluorescent test systems. Their dedication to advancing diagnostic technologies has been validated by over thirty worldwide publications confirming the superior performance of their products.
Generated from the website